دورية أكاديمية
Cardiovascular risk assessment using SCORE2 in a population with hypertension - the reality at a primary health care unit.
| العنوان: | Cardiovascular risk assessment using SCORE2 in a population with hypertension - the reality at a primary health care unit. |
|---|---|
| المؤلفون: | Pereira Santos S; Family Medicine Trainee, Portugal. Electronic address: scpsantos@arsnorte.min-saude.pt., Guedes S; Family Medicine Trainee, Portugal., Pesqueira R; Family Medicine Trainee, Portugal., Stuart J; Family Medicine Trainee, Portugal., Carvalho AM; Family Medicine Graduate Assistant, Portugal., Correia P; Family Medicine Graduate Assistant, Portugal., Lourenço Ribeiro I; Family Medicine Graduate Assistant, Portugal., Teixeira ÂM; Family Medicine Graduate Assistant, Portugal. |
| المصدر: | Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology [Rev Port Cardiol] 2024 Jul 12. Date of Electronic Publication: 2024 Jul 12. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English; Portuguese |
| بيانات الدورية: | Publisher: Lisbon Country of Publication: Portugal NLM ID: 8710716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2174-2030 (Electronic) Linking ISSN: 08702551 NLM ISO Abbreviation: Rev Port Cardiol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2011- : Lisbon : Elsevier Original Publication: Lisboa : Sociedade Portuguesa De Cardiologia |
| مستخلص: | Introduction and Objectives: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in Portugal, thus it is important to identify individuals at risk. Patients with hypertension have an increased risk of adverse cardiovascular (CV) events. The role of LDL cholesterol (LDL-C) in atherosclerotic CVD is well-established. SCORE2, a new CV risk calculation tool, is used to predict the 10-year risk of fatal or non-fatal CVD. The aim of this study was to understand the impact of SCORE2 on CV risk assessment in a population with hypertension from a moderate risk country, compared to the previously used SCORE. Methods: This observational cross-sectional study analyzed a population census of 3146 patients diagnosed with hypertension without complications (K86). After applying inclusion and exclusion criteria, 654 patients were included. Data from medical records were collected to calculate and compare SCORE and SCORE2 categories and LDL-C targets. Results: Patients were classified into SCORE categories: 188 (28.75%) low, 448 (68.5%) moderate, 17 (2.6%) high and 1 (0.15%) very high risk. Using SCORE2, individuals in the SCORE low risk category were reclassified, requiring new targets: 149 individuals (80%) as low to moderate and 39 (20%) as high risk. These differences became more evident when considering SCORE moderate and high-risk categories, where 358 patients (77%) received a higher CV risk categorization, and therefore a lower LDL-C target. There was a significant increase in individuals failing to meet the target when using SCORE2, compared to SCORE (p<0.001). Conclusion: These findings support the importance of CV risk assessment using SCORE2 algorithm in patients with hypertension. (Copyright © 2024 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Avaliação do risco cardiovascular; Doenças cardiovasculares; Gestão do C-LDL; Hipertensão; LDL-C management; Prevenção primária; Primary prevention; SCORE; SCORE2; cardiovascular disease; cardiovascular risk assessment; hypertension |
| تواريخ الأحداث: | Date Created: 20240714 Latest Revision: 20240714 |
| رمز التحديث: | 20240715 |
| DOI: | 10.1016/j.repc.2024.03.007 |
| PMID: | 39004141 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 2174-2030 |
|---|---|
| DOI: | 10.1016/j.repc.2024.03.007 |